Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Ovarian Cancer × niraparib × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 34 Prostatic Neoplasms 11 Breast Neoplasms 9 Fallopian Tube Neoplasms 7 Pancreatic Neoplasms 6 Glioblastoma 6 Endometrial Neoplasms 5 Neoplasms 4 Neoplasm Metastasis 4 Glioma 4 Small Cell Lung Carcinoma 3 Lung Neoplasms 3 Cholangiocarcinoma 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Recurrence 2 Mesothelioma, Malignant 2 Mesothelioma 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Ovarian Epithelial 2 Brain Neoplasms 2 Biliary Tract Neoplasms 2 Uveal Melanoma 1 Uterine Neoplasms 1 Urothelial Cancer 1 Unilateral Breast Neoplasms 1

Interventions

Saline Solution 2 Bevacizumab 2 senaparib 1 niraparib 1 Tranexamic Acid 1 Ropivacaine 1 Hyperthermic Intraperitoneal Chemotherapy 1 Antineoplastic Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07059676 2025-07-11

LIBINI-1

Clinica Universidad de Navarra, Universidad de Navarra

Not yet recruiting

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡